hospital anesthesia and cardiology markets and the excellent fit of Brevibloc with Sanofi Winthrop's existing product range, most notably with products such as Adenocor (adenosine) and Cordarone X (amiodarone), will result in further strong sales growth for Brevibloc in the U.
Gensia Sicor is transferring its licensed and proprietary medical products, including the Laryngeal Mask Airway, the GenESA(R) System, Brevibloc and the Feedback Controlled Heparin System into a wholly-owned subsidiary Gensia Automedics.
The 1994 second quarter financial results reflect the increases in sales and gross margin over prior year, which are primarily the result of increased sales by Gensia Laboratories, as well as continued increases in sales of the Laryngeal Mask Airway (LMA) in the United States and Brevibloc
The 1994 first quarter results reflect the significant increases in sales and gross margin, which are primarily the result of sales of etoposide and dobutamine by Gensia Laboratories, as well as continued increases in sales of the Laryngeal Mask Airway (LMA) and the launch of Brevibloc
is an ultra- short-acting intravenous beta-blocker indicated primarily for the treatment of perioperative tachycardia and hypertension with a secondary indication for the treatment of supraventricular tachycardia in emergency situations.
Earlier in the year the company added BREVIBLOC
, an injectable pharmaceutical for controlling heart rate, to its portfolio of products for use in critical care applications in the hospital.
(esmolol HCL) is a short-acting intravenous beta blocker used to control heart rate and blood pressure in the operating theatre and critical care settings.